Skip to main content
Journal of Biomedical Optics logoLink to Journal of Biomedical Optics
. 2015 Mar 4;20(3):038001. doi: 10.1117/1.JBO.20.3.038001

Study of tissue oxygen supply rate in a macroscopic photodynamic therapy singlet oxygen model

Timothy C Zhu 1,*, Baochang Liu 1, Rozhin Penjweini 1
PMCID: PMC4479436  PMID: 25741665

Abstract.

An appropriate expression for the oxygen supply rate (Γs) is required for the macroscopic modeling of the complex mechanisms of photodynamic therapy (PDT). It is unrealistic to model the actual heterogeneous tumor microvascular networks coupled with the PDT processes because of the large computational requirement. In this study, a theoretical microscopic model based on uniformly distributed Krogh cylinders is used to calculate Γs=g (1[O32]/[O32]0) that can replace the complex modeling of blood vasculature while maintaining a reasonable resemblance to reality; g is the maximum oxygen supply rate and [O32]/[O32]0 is the volume-average tissue oxygen concentration normalized to its value prior to PDT. The model incorporates kinetic equations of oxygen diffusion and convection within capillaries and oxygen saturation from oxyhemoglobin. Oxygen supply to the tissue is via diffusion from the uniformly distributed blood vessels. Oxygen can also diffuse along the radius and the longitudinal axis of the cylinder within tissue. The relations of Γs to [3O2]/[3O2]0 are examined for a biologically reasonable range of the physiological parameters for the microvasculature and several light fluence rates (ϕ). The results show a linear relationship between Γs and [3O2]/[3O2]0, independent of ϕ and photochemical parameters; the obtained g ranges from 0.4 to 1390  μM/s.

Keywords: singlet oxygen dosimetry, photodynamic therapy, oxygen diffusion, microscopic model, macroscopic model

1. Introduction

Photodynamic therapy (PDT) is a photochemical treatment modality used to treat malignant and nonmalignant conditions.1 It is generally believed that the therapeutic effect in PDT is mainly attributed to the production of singlet oxygen (O21), which involves the interaction of light, photosensitizer (PS), and ground-state oxygen (O23) in the target tissue.1 To evaluate the efficacy in generating O21, direct monitoring of O21 in vivo via singlet oxygen luminescence (SOL) at 1270 nm is preferable, but also technically challenging because of the short lifetime of O21 in real biological environments.24 Hence, the progress in transferring this direct approach to the clinic has not been significant in the past decade since the successful in vivo detection of SOL in 2002.5 Alternatively, explicit measurements of one or all three components in PDT are more feasible although an ideal approach still requires continuous measurements during PDT. Studies have been conducted to investigate the effects of light [including total delivered light fluence and fluence rate (ϕ)] and PS concentration on PDT efficacy both in vitro and in vivo (PDT dosimetry).1,613 The effect of oxygenation is much more easily examined in the in vitro model,14 because it is relatively difficult to monitor and quantify the spatial distribution of oxygen continuously and noninvasively in a real biological system.

To completely characterize the PDT treatment outcomes and interpret experimental results, mathematical modeling of the complex PDT mechanisms and the production of O21 are suggested.13 The basic mathematical descriptions of the photochemical and photophysical reactions during PDT can then be adopted into an in vitro and/or in vivo biological environment to calculate the temporal and spatial distributions of PDT components (PS, O23 and O21 concentrations and ϕ).13,1517 A macroscopic PDT model was developed to extract the so-called reacted singlet oxygen [(O12)rx] threshold dose at tumor tissue necrotic distances by fitting the calculated O21 profile to measured necrosis induced by interstitial PDT.13 This model considers light diffusion and a set of PDT kinetics equations incorporating the oxygen consumption rate per ϕ and PS concentration (ξ), the probability ratio of an O21 molecule reacting with ground-state PS compared to the O21 molecule reacting with a cellular target (σ), and the ratio of the monomolecular decay rate of the triplet state (T) PS to the bimolecular rate of the triplet PS quenching by O23 (β), which can be potentially used as clinically practical dosimetry quantities. In this macroscopic model, the molecular oxygen supply rate to the target tissue was hypothesized as a linear function of fractional O23 concentration (the ratio of volume average oxygen concentration to its initial value prior to PDT) with a maximum supply rate (g), as shown in Eq. (1).

Γs=g[1[O23][O23](t=0)]. (1)

Preliminary results were presented on fitting the necrotic radius induced by interstitial Photofrin-mediated PDT to obtain model parameters (ξ, σ, β, and g) and [O12]rx. Then, the sensitivity of the model parameters to calculated [O12]rx profiles has been explored for different light source geometries and PSs in in vivo interstitial conditions.13 A comparison of the computed [O12]rx distributions showed that the model can be potentially correlated to differences in PDT efficacy.

In the current study, a microscopic model incorporating biological blood vasculature distribution is used to investigate an appropriate simple expression for oxygen supply which can be used in our macroscopic model. Due to the large computational requirement, modeling of the heterogeneity of tumor microvascular networks coupled with the PDT processes is at present impractical. The ultimate objective of this study is to replace the complex modeling of blood vasculature with a simplified expression for oxygen supply to tissue while maintaining reasonable accuracy. The findings of the present studies justify that our previously hypothesized linear expression in the macroscopic PDT model is sufficient to replace microscopically modeling oxygen supply in tissue. The values of g=0.72.0  μM/s as determined in the literature13,18 for a number of PSs are also found to be within the range of g values calculated in this study for the range of the physiological parameters being tested.

2. Theory and Method

2.1. Macroscopic Model for Photodynamic Therapy

The macroscopic PDT model is briefly described in this section, as well as the definitions of the five parameters to be optimized during the process of fitting in the in vivo experimental results. The intention of this work is to investigate the oxygen supply term in the model using a microscopic model instead of fitting experimental results to derive parameters. More detailed descriptions of the model and the fitting routine can be found elsewhere.13

In the macroscopic model,13 spatial distribution of ϕ in the tumor is calculated via Eq. (2) based on the diffusion approximation. Temporal and spatial distributions of PS (S0), [O23] and [O21] concentrations are obtained by solving a set of coupled time-dependent differential Eqs. (3) to (5). The cumulative concentration of [O12]rx can then be derived by the integration of Eq. (5) over time (t). In Eq. (4), the symbol Γs denotes the rates at which O23 is supplied to the surrounding tissue, which is the term to be examined in this study.

μaϕ·(13μsϕ)=S, (2)
d[S0]dt+[ξσϕ([S0]+δ)[O23][O23]+β][S0]=0, (3)
d[O23]dt+{ξϕ[S0][1+σ([S0+δ])][O23]+β}[O23]=Γs, (4)
d[O21]rxdtf·[ξϕ([S0][O23])[O23]+β]=0. (5)

The parameters μs and μa represent optical scattering and absorption coefficients, respectively. δ is the low concentration correction parameter and S describes the light source. The mathematical definitions of all parameters are given in Tables 1 and 2. Some reported values of the photochemical parameters for Photofrin are shown in Table 1.13

Table 1.

Photodynamic therapy (PDT) photochemical parameters used for calculations for Photofrin.13

Parameters Values Definitions
ξ (cm2mW1s1) 3.70×103 SΔk5/(k3+k5)ε/hυ/(k6/k7[A]+1)
σ (μM1) 7.60×105 k1/(k7[A])
δ (μM) 33.00 Low concentration correction
β (μM) 11.90 k4/k2
μs (cm1) 13.46 Optical reduced scattering coefficient
μa (cm1) 1.03 Optical absorption coefficient

Table 2.

Definitions of the photochemical parameters.

Symbols Definitions Units
k1 Photobleaching rate 1/μM·s
k2 Reaction rate of O32 with T 1/μM·s
k3 Rate of S1 to S0 1/s
k4 Rate of T to S0 1/s
k5 Rate of S1 to T 1/s
k6 Rate of O12 to O32 1/s
k7 React. rate of O12 and tissue 1/μM·s
ε Extinction coefficient cm1μM1
g Maximum oxygen supply rate μM/s
[S0] Ground state sensitizer concentration μM
[S1] Singlet excited state sensitizer concentration μM
[T] Triplet excited state sensitizer concentration μM
[O32] Triplet ground state oxygen concentration μM
[O12] Singlet excited state oxygen concentration μM
SΔ Fraction [O12] from [T] and [O32] reaction Dimensionless

2.2. Microscopic Model for Photodynamic Therapy

A microscopic PDT model was developed based on the Krogh cylinder model.19 In the model, the tumor has uniformly spaced cylindrical blood capillaries (with a radius of Rc) in parallel with the linear light source. The inter-capillary distance between two adjacent capillaries is assumed to be large enough so that each capillary can supply oxygen only to its immediate concentric surrounding tissue. The oxygen concentration in the oxygen supply term as expressed in Eq. (1) will be an average value over the entire tissue element volume. Due to the values of both inter-capillary distance (Rt) and capillary length (lz) used in this study, it is reasonable to assume that ϕ within the small tissue element in Fig. 1 is constant. Figure 1 shows the schematic of the cylindrical Krogh model. Note that a three-dimensional Krogh model can be simplified as a 2-D cylindrical symmetric model given the above assumptions.

Fig. 1.

Fig. 1

(a) A schematic of the Krogh cylinder model. (b) three-dimensional (3-D) mesh plot of the Krogh cylinder model. The light fluence rate within the Krogh model is considered to be a constant because the spatial scale of light transport (1 to 10 mm) is much larger than the spatial scale of the Krogh model (<0.4  mm=400  μm). The incident direction of light is randomly distributed.

Before introducing the governing equations for oxygen and its carrier, oxyhemoglobin (HbO), some basic physiological assumptions are discussed first. Oxygen is normally present in the blood in two forms: chemically bound to hemoglobin forming HbO, and free molecules dissolved in the plasma. Most oxygen is bound to form HbO, which is contained in the red blood cell (RBC). However, there is still a small fraction of oxygen dissolved in the liquid media such as blood plasma and RBC water. The concentration of these free oxygen molecules can be represented using a quantity called oxygen partial pressure (P). The relation between them can be defined using Henry’s law in Eq. (6), where α is the oxygen solubility coefficient:

[O32]=αP. (6)

When P decreases in the surrounding environment, HbO will release oxygen and vice versa. The percentage of hemoglobin that is saturated with oxygen is usually referred to as hemoglobin oxygen saturation (SaO2). The relationship between P and SaO2 is described by Hill’s oxygen dissociation curve. A mathematic expression for O23 dissociation is Hill’s equation, as shown in Eq. (7):16

Sa=PnPn+P50n, (7)

where P50 represents the half maximum hemoglobin saturation pressure. n is the Hill coefficient representing the degree of co-operativity.

Oxygen molecules can diffuse freely from RBC into the blood stream due to negligible resistance in the membrane.19 Therefore, the first assumption is that released oxygen from HbO can instantaneously be present in blood plasma (i.e., ignoring the diffusion from RBC). The second assumption is that RBCs are uniformly distributed in the blood.

Given the above assumptions, the time-dependent governing equations for O23 and HbO transport inside the capillary are given in Eqs. (8) and (9). First, note that the concentration of O23 is hereafter expressed using the partial pressure of O23 (P) based on Eq. (6) because of the continuity boundary conditions that will be discussed later. Second, Sa in Eq. (9) is the hemoglobin oxygen saturation describing the percentage of HbO concentration to total hemoglobin concentration.

αcPt=αcDc2Pv·αcP+Γrec, (8)
CHSat=CHDH2Sav·CHSaΓrec. (9)

The product of Sa and CH (total hemoglobin concentration in capillary) is the HbO concentration. The first terms on the right hand sides of Eqs. (8) and (9) are the diffusion terms of O23 and hemoglobin, respectively; the second terms describe the convection processes. The third term (Γrec) is the so-called “reaction” term representing the O23 loading/unloading from deoxyhemoglobin/oxyhemoglobin. The parameters Dc and DH represent the diffusion coefficients of O23 and hemoglobin in the capillary, respectively. αc is the solubility of O23 in plasma and v is the blood velocity in the capillary.

By manipulating Eqs. (7) to (9), one can derive the main governing Eq. (10) for P in the capillary, where K and M are defined in Eqs. (11) and (12), respectively.

(αc+KCH)Pt=(αcDc+KCHDH)2P(νzαc+νzKCH)Pz+CHDHM[(Pr)2+(Pz)2], (10)
K=nPn1P50n(Pn+P50n)2, (11)
M=n(n1)P50nPn2(Pn+P50n)2n2P(2n2)P50n(Pn+P50n)3, (12)

where r and z are the radial and axial variables, respectively. vz is the axial blood flow velocity.

The boundary conditions in the microscopic model are summarized in Eqs. (13) to (16). The bottom end of the capillary (i.e., z=0) is the entrance of blood flow, which is assumed to have a constant O23 partial pressure Pts. On the boundary between capillary and tissue, both O23 flux and P are continuous as shown in Eqs. (14) and (15). Other boundaries are considered as insulation.

P|z=0,r[0,Rc]=Pts, (13)
DcαcP|r=Rc=DtαtP|r=Rc+, (14)
P|r=Rc=P|r=Rc+, (15)
P|other=0. (16)

The parameters αt and Dt are the solubility and diffusion coefficients of oxygen in tissue, respectively.

The governing equation for [O23] in tissue during PDT in the microscopic model is given by Eq. (17), which has the same terms on the left-hand side as Eq. (4) to describe PDT consumption of oxygen. The right-hand side of the equation contains both O23 diffusion (the first term) and the metabolic consumption (the second term). However, only a general oxygen supply term Γs is used in the macroscopic model [as shown in Eq. (4)].

[O23]t+{ξϕ[S0][O23][1+σ([S0]+δ)][O23]+β}=Dt2[O23]q0[O23][O23]+αtPm. (17)

The parameter q0 represents the maximum metabolic O23 consumption rate and Pm is the half-maximum oxygen consumption.

Table 3 presents the magnitude of the physiological parameters based on the literature values for the normal and tumor tissues by either measurements (in both living animals and fixed tissues) or theoretical studies.16,1925 The normal capillaries appear as fine, nearly parallel vessels that are served by orderly branching arterial and venous trees.21 In contrast, the tumor vessels are disorganized, leaving large, irregular avascular spaces.21 We tried to cover the existing wide range data sets representing both normal and cancer tissues in our study.

Table 3.

Physiological parameters in the microscopic PDT model. The standard values are considered as the benchmark condition for the comparison.

Parameters Ranges Standard values Description
Rt 18–6019,20,21 60 Radius of cylindrical tissue (μm)
Rc 2.5–1019,20,21 4 Radius of cylindrical capillary (μm)
Dt   170019 O32 diffusion coefficient in tissue (μm2/s)
Dc   124024 O32 diffusion coefficient in capillary (μm2/s)
αt   1.29519 O32 solubility in tissue (μM/mmHg)
αc   1.52719 O32 solubility in plasma (μM/mmHg)
vz 50–20019,24 10024 Blood flow velocity (μm/s)
P50   2616 Half maximum hemoglobin saturation pressure (mmHg)
CH   250026,* Total hemoglobin concentration in capillary (μM)
q0 0.9–6 2.419 O32 maximum metabolic consumption rate (μM/s)
n   2.4624 Hill constant
Pm   0.38624 pO2 at half maximum oxygen consumption concentration (mmHg)
Pts 50, 10019,25,27 10025 Artery O32 partial pressure (mmHg)
DH   1419 Hemoglobin diffusion coefficient in capillary (μm2/s)
lz 100–40019,20 220 Length of capillary (μm)

Note: * The hemoglobin concentration in a red blood cell is 5000μM.16 Thus the hemoglobin concentration is 2500μM after we factor in the fraction of the red blood cell, ie. hematocrit, in blood is about 50%.26

2.3. Simulation, Procedures, and Initial Conditions

The microscopic model was simulated by the finite element method (FEM) analysis, solver, and simulation software package COMSOL Multiphysics v4.3b (Comsol AB, Stockholm, Sweden), which was run on an iMAC OSX version 10.9.5 (Processor 3.1 GHz Intel Core 17 and Memory 16 GB 1600 MHz DDR3). LiveLink for MATLAB® was also used to work with COMSOL Multiphysics in combination with MATLAB R2013a (64-bit, Massachusetts).

The first step was to examine an expression for oxygen supply. For this purpose, the instantaneous total change rates of O23 in tissue [i.e., the sum of the two terms on the right-hand side of Eq. (17)] were calculated, and then plotted as a function of the instantaneous oxygen concentration at the corresponding time normalized to its value prior to PDT ([O23]/[O23]0). These simulations were first performed for a range of ϕ (25 to 150  mW/cm2), and some typical treatment conditions for Photofrin-, mTHPC-, BPD-, and HPPH-mediated PDT. Different photochemical parameters ξ (3.7×10376×103  cm2mW1s1), σ (1.55×1057.6×105  μM1) and β (8.7 to 11.9  μM) were used in this step. The results were analyzed together to see the ϕ, ξ, σ, and β dependence.

The main objective of the second step was to find g values in Photofrin-mediated PDT for a range of physiological microenvironments at ϕ=150  mW/cm2. The initial Photofrin concentration in the tissue was assumed to be 7  μM and total treatment time was chosen to be 100 min. The standard values of the PDT photochemical and physiological parameters, reported by the other studies, were used as shown in Tables 1 and 3.16,1925 The radius of the capillary (Rc=2.5, 4.0 or 10  μm), the length of the capillary (lz=100, 220 or 400  μm), the density of blood vessels (Rt=18, 30 or 60  μm), the blood flow velocity (vz=50, 100 or 200  μm/s), and maximum O32 metabolic consumption rate (q0=0.9, 2.4 or 6  μM/s) were set at three different values, which cover the existing data sets representing both normal and tumor vasculatures.1924 The magnitude of Pts was set at two different values of 50 and 100 mmHg representing O32 partial pressure in both tumor and normal arteries.19,2225, 27 For the simulations, the physiological parameters were first set at their standard values and then the magnitude of Rc, Rt, vz, q0, Pts and lz were varied from their standard values. The varied parameters with their values are listed in Table 4 along with the fitted results in the next section.

Table 4.

Physiological parameters varied for the range of microenvironment examined for g.

Pts (mmHg) q0 (μM/s) vz (μm/s) lz (μm) g (μM/s)
Rc;Rt (μm)
2.5;60 4;60 2.5;30 10;60 4;30 2.5;18 4;18 10;30 10;18
100 0.9 50 220 0.9 2.3 4.0 8.6 6.6 8.3 16.8 28.3 80.1
100 220 2.0 4.4 7.0 17.2 14.9 15.5 29.1 51.9 147.0
200 220 4.2 7.9 11.9 27.2 23.1 26.1 56.0 104.2 279.6
2.4 50 220 0.9 2.1 4.1 10.6 8.8 9.1 18.5 28.8 82.7
100 220 2.0 4.9 8.3 17.7 15.4 17.3 31.2 61.1 149.1
200 220 3.9 7.9 13.9 36.4 30.6 31.7 87.2 104.9 282.7
6 50 220 0.9 2.0 4.1 12.1 9.2 9.5 23.3 35.7 89.9
100 220 2.0 4.9 9.2 20.0 15.9 18.2 33.2 68.7 155.7
200 220 4.4 7.8 14.5 31.1 26.1 29.0 55.8 109.9 286.1
50 0.9 50 220 0.6 2.3 4.2 10.8 10.8 12.4 25.5 49.1 151.7
100 220 1.9 4.6 8.2 18.8 18.7 23.0 44.0 93.8 297.5
200 220 3.4 8.1 14.4 37.6 34.0 48.7 89.0 167.1 601.5
2.4 50 220 0.9 2.2 3.9 10.8 11.3 14.5 27.4 51.2 152.2
100 220 1.9 4.6 8.9 20.4 17.9 25.4 49.0 93.9 305.6
200 220 3.4 7.5 15.2 37.7 30.8 45.7 88.2 167.2 604.6
6 50 220 1.0 2.3 4.4 11.0 10.7 14.9 33.5 55.8 161.8
100 220 1.9 4.6 7.4 20.7 16.0 25.8 52.2 94.3 325.5
200 220 3.6 5.5 15.7 45.5 30.7 54.0 86.4 168.5 606.9
100 2.4 100 100 4.9 7.7 13.0 37.7 29.7 30.7 75.4 111.2 277.3
100 220 2.0 4.9 8.3 17.7 15.4 17.3 31.2 61.1 149.1
100 400 1.0 2.3 5.1 9.5 10.7 11.0 19.9 30.2 88.1
50 2.4 100 100 3.1 7.7 16.5 38.9 36.7 51.4 99.6 158.9 642.3
100 220 1.9 4.6 8.9 20.4 17.9 25.4 49.0 93.9 305.6
100 400 0.9 2.2 3.8 9.7 8.9 13.2 32.6 57.7 204.2

3. Results and Discussions

3.1. Linear Correlation and g Calculation for Different Photochemical Parameters and Fluence Rates in a Capillary with Standard Physiological Parameters

Figures 2(a) and 2(b) show the volume-averaged oxygen supply rate and O32 concentration over the whole Krogh cylinder as a function of time, calculated using the microscopic model for standard values presented in Table 3 and ϕ=25, 50, 75, 100, and 150  mW/cm2. Based on our calculations, the initial volume-averaged oxygen concentration [O32]0, prior to Photofrin-mediated PDT (with ξ=3.7×103  cm2mW1s1, σ=7.6×105  μM1, β=11.9  μM, δ=33  μM), was around 39.41  μM. The corresponding volume-averaged oxygen supply rate versus [O32]/[O32]0 is presented in Fig. 2(c), which is “zero” prior to PDT and shows a linear correlation independent of ϕ. A linear fit to these data (has an intercept at 1 on x-axis) results in a slope of about 4.9±0.1, which represents the g value in μM/s with the standard deviation of the mean (STDM). The simulations were also performed for different PSs: mTHPC (with ξ=30×103  cm2mW1s1, σ=2.97×105  μM1, β=8.7  μM, δ=33  μM), BPD (with ξ=51×103  cm2mW1s1, σ=1.7×105  μM1, β=11.9  μM, δ=33  μM) and HPPH (with ξ=76×103  cm2mW1s1, σ=1.55×105  μM1, β=11.9  μM, δ=33  μM) at ϕ=150  mW/cm2. The volume-averaged oxygen supply rate versus [O32]/[O32]0 is presented in Fig. 2(d) and shows a linear correlation independent of ξ, σ and β. The linear fit to these data results in a g value of about 5.1±0.2  μM/s (g is presented with STDM). While the g value is extremely sensitive to change in the physiological parameters and O32 concentration, the results show that g is independent of ϕ and PS photochemical parameters.

Fig. 2.

Fig. 2

(a) Oxygen supply rate [right-hand side of Eq. (17)] and (b) oxygen concentration, defined as the volumetric average around each vessel versus time. The plots are for ϕ=25, 50, 75, 100, and 150  mWcm2. (c) The mean oxygen supply rate versus normalized mean oxygen for different ϕ. A linear fit to the spectra (as shown with red lines) results an average slope of about 4.99±0.10, which is g(μM/s)±STDM. (d) The mean oxygen supply rate versus normalized oxygen for different photosensitizers (PSs), Photofrin (ξ=3.7×103  cm2mW1s1, σ=7.6×105  μM1, β=11.9  μM, δ=33  μM), mTHPC (ξ=30×103  cm2mW1s1, σ=2.97×105  μM1, β=8.7  μM, δ=33  μM), BPD (ξ=51×103  cm2mW1s1, σ=1.7×105  μM1, β=11.9  μM, δ=33  μM) and HPPH (ξ=76×103  cm2mW1s1, σ=1.55×105  μM1, β=11.9  μM, δ=33  μM). A linear fit to the spectra (as shown with red lines) results g=5.12±0.17  μM/s. The data are plotted for the physiological parameters with standard values presented in Table 3. Normalized mean oxygen is defined as the volumetric average of O32 around each vessel divided by [O32]0, which is the initial mean oxygen before PDT.

3.2. Representative g Value Tests on More Than One Varying Parameter

The g values were calculated for Photofrin-mediated PDT and a range of physiological parameters at ϕ=150  mW/cm2. In our model, the blood vessel network forms uniformly distributed Krogh cylinders and the spacing between vascular cylinders Rt varies between 18 and 60  μm. The cylindrical blood capillary has Rc in the range of 2.5 to 10  μm and lz in the range of 100 to 400  μm. For both tumor and normal vasculatures, the maximum O32 metabolic consumption rate (q0) and blood velocity in capillary (vz) are in the ranges of 0.9 to 6  μM/s and 50 to 200  μm/s, respectively (see Table 3). The oxygen pressure at the aortal entrance of the blood vessel (Pts) is assumed to be in the range of 50 or 100 mmHg.19,25,27 The linear correlation between the volume-averaged oxygen supply rate and [O32]/[O32]0 as well as their respective g values is presented in Figs. 3 to 5 and Table 4. The linear fits to the data result in g values in the ranges of 0.9 to 286.1  μM/s for Pts=100  mmHg and 0.6606.9  μM/s for Pts=50  mmHg.

Fig. 3.

Fig. 3

Calculated mean oxygen supply rate [right side of Eq. 17] versus normalized mean oxygen, [O32]/[O32]0. The data are plotted for artery oxygen partial pressure Pts=100  mmHg, capillary length lz=220  μm as well as different blood flow vz and maximum metabolic oxygen consumption rate q0. Each plot contains nine combinations of cylindrical tissue radius Rt  (18,30,60  μm) and capillary radius Rc  (2.5,4,10  μm) as presented with different colors and symbols. The 3 plots for the left column are for vz=50  μm/s and q0=0.9,2.4, and 6  μM/s, respectively; the 3 plots for the middle column are for vz= 100  μm/s and q0=0.9,2.4, and 6  μM/s, respectively; the 3 plots for the right column are for vz=200  μm/s and q0=0.9,2.4, and 6  μM/s, respectively. The calculated g values are in the range of 0.89–286.09  μM/s.

Fig. 4.

Fig. 4

Calculated mean oxygen supply rate [right side of Eq. 17] versus normalized mean oxygen, [O32]/[O32]0. The data are plotted for artery oxygen partial pressure Pts=50  mmHg, capillary length lz=220  μm as well as different blood flow vz and maximum metabolic oxygen consumption rate q0. Each plot contains nine combinations of cylindrical tissue radius Rt  (18,30,60  μm) and capillary radius Rc  (2.5,4,10  μm) as presented with different colors and symbols. The 3 plots for the left column are for vz=50  μm/s and q0=0.9,2.4, and 6  μM/s, respectively; the 3 plots for the middle column are for vz= 100  μm/s and q0=0.9,2.4, and 6  μM/s, respectively; the 3 plots for the right column are for vz=200  μm/s and q0=0.9,2.4, and 6  μM/s, respectively. The calculated g values are in the range of 0.59–606.96  μM/s.

Fig. 5.

Fig. 5

Calculated mean oxygen supply rate [right side of Eq. 17] versus normalized mean oxygen, [O32]/[O32]0. The data are plotted for blood flow vz=100  μm/s, maximum metabolic oxygen consumption rate q0=  2.4  μM/s as well as different artery oxygen partial pressure Pts and capillary length lz. Each plot contains 9 combinations of cylindrical tissue radius Rt  (18,30,60  μm) and capillary radius Rc  (2.5,4,10  μm) as shown with different colors and symbols. The 3 plots for the left column are for Pts=100  mmHg and lz=100,220,and 400  μm, respectively; the 3 plots for the right column are for Pts=50  mmHg and lz=100,220,and 400  μm, respectively. The g values are in the ranges of 1.01–277.33  μM/s and 0.93–642.25  μM/s for Pts=100 and 50  mmHg, respectively.

3.3. Formulation of g Directly from Blood Vessel Physiological Parameters

The convective oxygen delivery (Q) is related to the product of blood flow (vzπRc2) and oxygen concentration by Fick’s principle:28

Q=πRc2vz[O32]. (18)

Oxygen continuously diffuses from the plasma to the tissue (with the volume of πRt2lz) where it is consumed. If one assumes that all the capillaries perfusing the tissue are identical and that the oxygen consumption is uniform within the small tissue element shown in Fig. 1(a), then the amount of O32 removed from the volume of blood per unit length along the capillary (πRc2) is constant. The amounts of oxygen moving across the capillary wall is proportional to that consumed by tissue which is supplied by the capillary:28

πRc2vz[O32]gπRt2lz=const. (19)

Figures 3 to 5 describing the changes of g with vz, Rc, Rt, and lz show close agreement with Fick’s principles. While with the same conditions of Rt and Rc, the resulting g values decreased roughly by 1/lz, g linearly increased with vz; g showed a nonlinear relationship with Rc, Rt, and q0. On the basis of the reduced chi-squared (0.96χ21), the g values versus Rc [Fig. 6(a)], Rt [Fig. 6(b)], vz [Figs. 6(c)], and lz [Figs. 6(d)] were best fitted with a second-order polynomial, second power decay, linear, and first power decay curves, respectively. The fitting equations were used to obtain an empirical Eqs. (20) and (21) that can calculate g directly from vz, Rc, Rt, lz, and q0 for two Pts conditions:

Pts=100  mmHg:g[μM/s]=1200vz[μm/s]Rc[μm](Rc[μm]+[1002+q02[μM/s](50)2q02[μM/s]]),lz[μm](Rt[μm]+4.2)2 (20)
Pts=50  mmHg:g[μM/s]=1200vz[μm/s]Rc[μm](Rc[μm]+[502+q02[μM/s](50)2q02[μM/s]])lz[μm](Rt[μm]4.2)2. (21)

Fig. 6.

Fig. 6

g versus (a) Rc, (b) Rt, (c) vz, (d) lz, and (e) q0 for Pts=100  mmHg (in the left column) and Pts=50  mmHg (in the right column). The vasculature conditions assumed to have the standard values presented in Table 3. The actual g values (filled-set symbols) are compared with those calculated by using Eqs. (20) and (21) (empty-set symbols). On the basis of the reduced chi-squared (0.96χ21), the g values versus Rc, Rt, vz, and lz were best fitted with second-order polynomial, second power decay, linear and first power decay curves, respectively.

The relationship between g and q0 as well as the constant values were obtained and optimized manually based on the relative errors of the actual g and those obtained by Eqs. (20) and (21). For the range of microenvironments shown in Table 3, Eqs. (20) and (21) determine g values in the ranges of 0.6 to 685.3  μM/s for Pts=100  mmHg and 0.4 to 1390  μM/s for Pts=50  mmHg. The maximum g value of 1390  μM/s is obtained for Rc=10  μm, Rt=18  μm, vz=200  μm/s, Pts=50  mmHg, q0=6  μM/s, and lz=100  μm. The minimum g value of 0.4  μM/s is calculated for Rc=2.5  μm, Rt=60  μm, vz=50  μm/s, Pts=50  mmHg, q0=0.9  μM/s, and lz=400  μm. Table 5 shows the results of Eqs. (20) and (21) for the physiological parameters listed in Table 3. The g values are presented with the standard deviations obtained from the actual FEM results and the calculated values from Eqs. (20) and (21). The relative errors were also measured as the percentages of the deviations divided by the FEM calculated g values. The maximum error of 27% occurs for the blood vessel with Pts=100  mmHg, q0=0.9  μM/s, vz=200  μm/s, lz=220  μm, Rc=2.5  μm, and Rt=18  μm; the minimum error of 0.03% occurs for the blood vessel with Pts=100  mmHg, q0=6  μM/s, vz=100  μm/s, lz=220  μm, Rc=10  μm and Rt=18  μm.

Table 5.

The calculated g values using Eqs. (20) and (21) for the same microenvironment ranges examined for the actual g obtained by FEM simulation. The values are presented with the standard deviations obtained from the actual FEM results and the calculated values from Eqs. (20) and (21). The maximum relative (standard) deviation of the fits is 12.82%.

  vz (μm/s) lz (μm) g (μM/s) calculated from Eqs. (20) and (21)
Rc;Rt (μm)
2.5;60 4;60 2.5;30 10;60 4;30 2.5;18 4;18 10;30 10;18
Pts=100  mmHgq0=0.9  μM/s 50 220 1.0±0.1 2.1±0.1 3.8±0.2 9.3±0.5 7.5±0.6 9.0±0.5 17.7±0.6 32.6±3.1 77.5±1.9
100 220 2.2±0.1 4.2±0.1 7.6±0.4 18.5±0.9 14.9±0.1 18.0±1.7 35.4±4.5 65.3±9.5 155.0±5.6
200 220 4.3±0.1 8.5±0.4 15.2±2.3 37.1±7.0 29.9±4.8 36.0±7.0 70.9±10.5 130.6±18.7 309.9±21.5
Pts=100  mmHgq0=2.4  μM/s 50 220 1.1±0.1 2.1±0.01 3.8±0.2 9.3±0.9 7.5±0.9 9.0±0.1 17.7±0.5 32.7±2.7 77.5±3.7
100 220 2.2±0.1 4.2±0.4 7.6±0.5 18.5±0.6 14.9±0.3 18.0±0.5 35.5±3.0 65.3±3.0 155.1±4.3
200 220 4.3±0.3 8.5±0.4 15.2±0.9 37.1±0.5 29.9±0.5 36.0±3.1 70.9±11.5 130.7±18.2 310.2±19.4
Pts=100  mmHgq0=6.0  μM/s 50 220 1.1±0.1 2.1±0.1 3.8±0.2 9.3±2.0 7.5±1.2 9.1±0.3 17.9±3.8 32.8±2.1 77.9±8.5
100 220 2.2±0.1 4.3±0.4 7.8±1.0 18.6±1.0 15.1±0.6 18.2±0.02 35.7±1.8 65.6±2.2 155.8±0.1
200 220 4.4±0.1 8.6±0.5 15.3±0.6 37.2±4.4 30.1±2.8 36.4±5.2 71.5±11.1 131.3±15.1 311.5±18.0
Pts=50  mmHgq0=0.9  μM/s 50 220 0.8±0.1 1.8±0.4 3.6±0.5 9.6±0.8 8.2±1.9 12.5±0.1 28.7±2.2 45.1±2.8 157.5±4.1
100 220 1.5±0.2 3.5±0.8 7.2±0.7 19.3±0.4 16.4±1.6 25.1±1.5 57.3±9.4 90.1±2.6 315.1±12.4
200 220 3.1±0.2 7.0±0.7 14.3±0.1 38.5±0.7 32.8±0.9 50.1±1.0 114.6±18.1 180.3±9.3 630.2±20.2
Pts=50  mmHgq0=2.4  μM/s 50 220 0.8±0.1 1.8±0.3 3.6±0.2 9.9±0.6 8.2±2.2 12.6±1.4 28.7±0.9 45.1±4.3 157.6±3.8
100 220 1.5±0.3 3.5±0.8 7.2±1.2 19.3±0.8 16.4±1.1 25.1±0.2 57.3±5.9 90.2±2.6 315.2±6.8
200 220 3.1±0.2 7.0±0.3 14.4±0.6 38.6±0.6 32.8±1.4 50.2±3.2 114.7±18.7 180.4±9.3 630.4±18.2
Pts=50  mmHgq0=6.0  μM/s 50 220 0.8±0.1 1.8±0.4 3.6±0.6 9.7±1.0 8.2±1.7 12.6±1.6 28.8±3.3 45.2±7.5 158.0±2.7
100 220 1.6±0.2 3.5±0.8 7.2±0.1 19.3±1.0 16.5±0.4 25.3±0.3 57.6±3.8 90.4±2.8 315.9±6.8
200 220 3.1±0.3 7.1±1.1 14.5±0.9 38.6±4.9 33.0±1.6 50.5±2.5 115.2±20.4 180.8±8.7 631.8±17.6
Pts=100  mmHgq0=2.4  μM/s 100 100 4.7±0.1 9.3±1.1 16.7±2.6 40.8±2.2 32.9±2.2 39.6±6.3 78.0±1.9 143.8±23.1 341.2±45.1
100 220 2.2±0.1 4.2±0.4 7.6±0.5 18.5±0.6 14.9±0.3 18.0±0.5 35.5±3.0 65.3±3.0 155.1±4.3
100 400 1.2±0.1 2.3±0.1 4.3±0.6 10.2±0.5 8.2±1.7 9.9±0.8 19.5±0.3 35.9±4.1 85.3±2.0
Pts=50  mmHgq0=2.4  μM/s 100 100 3.4±0.2 7.7±0.01 15.8±0.5 42.4±2.5 36.1±0.4 55.2±2.7 126.1±18.8 198.4±27.9 693.4±36.2
100 220 1.5±0.3 3.5±0.8 7.2±1.2 19.3±0.8 16.4±1.1 25.1±0.2 57.3±5.9 90.2±2.6 315.2±6.8
100 400 0.8±0.1 1.9±0.2 4.0±0.1 10.6±0.6 9.0±0.1 13.8±0.4 31.5±0.7 49.6±5.7 173.4±21.8

4. Conclusion

The accurate estimation of the maximum oxygen supply rate, g, is very important for the mathematical investigation of complex PDT mechanisms. In this study, we suggested a simplified expression for g that can replace the complex modeling of blood vasculature while maintaining reasonable accuracy. Using the microscopic model, the relationship of the oxygen supply rates versus [O32]/[O32]0 has been examined for Photofrin-mediated PDT treated at ϕ ranging from 25 to 150  mW/cm2; the slope of the linear fit to these data represents the g value in μM/s. The simulations have been also tested for different photochemical parameters corresponding to mTHPC-, BPD-, and HPPH-mediated PDT. The obtained results showed a linear relationship independent of ϕ, ξ, σ, and β. The possible g values in Photofrin-mediated PDT were then calculated for a broad range of physiological parameters that have been measured in the past for normal and tumor vasculatures. Examination reveals that the g values can range from 0.4 to 1390  μM/s depending on the actual physiological environment. The maximum g value of 1390  μM/s was obtained for blood vessels with Rc=10  μm, Rt=18  μm, vz=200  μm/s, Pts=50  mmHg, q0=6  μM/s, and lz=100  μm. The minimum g value of 0.41  μM/s was calculated for Rc=2.5  μm, Rt=60  μm, vz=50  μm/s, Pts=50  mmHg, q0=0.9  μM/s, and lz=400  μm.

Based on Fick’s principle,28 if all the capillaries perfusing the tissue are identical and the oxygen consumption is uniform within the tissue element, the amount of oxygen moving across the capillary wall is proportional to that consumed by tissue which is supplied by the capillary (vzπRc2[O32]gπRt2lz). This is in close agreement with our simulation outcome which estimates g to increase with decreasing lz (first power decay) and Rt (second power decay) and increasing Rc (quadratic second-order polynomial enhancement), and vz (linear enhancement). Our model also anticipates g to increase nonlinearly and slowly with q0.

A comparison of our estimated g values with those obtained by the previous in vivo studies shows that our calculation is accurate and the g value can be potentially used for our macroscopic model [Eqs. (15)].

Acknowledgments

We thank the useful discussions with Dr. Jarod C. Finlay on the theory. This research was supported by the National Institute of Health (NIH R01 CA 154562).

Biographies

Timothy C. Zhu received his PhD degree in 1991 in physics from Brown University. He is currently a professor in the Department of Radiation Oncology at the University of Pennsylvania. His current research interests include explicit PDT dosimetry, singlet oxygen explicit dosimetry (SOED), integrated system for interstitial and intracavitory PDT, diffuse optical tomography, in vivo dosimetry, and external beam radiation transport.

BaochangLiu received his PhD degree in medical physics in 2012 from McMaster University, where he specialized in photodynamic therapy (PDT) dosimetry. He continued his research as a postdoctoral fellow in the Department of Radiation Oncology at the University of Pennsylvania. His research interests include modeling PDT dosimetry and oxygen transport in tissue, in vivo explicit dosimetry for interstitial PDT, developing direct O12 dosimetry system, and tissue optics.

RozhinPenjweini received her PhD degree in 2012 in physics from the University of Vienna. She is currently a postdoctoral researcher in the Department of Radiation Oncology at the University of Pennsylvania. Her current research interest is in vivo explicit PDT and singlet oxygen dosimetry. She also has practical experience in various fluorescence microscopy techniques for studying the structure, transport, and stability of nanomedicines for PDT treatment of cancer.

References

  • 1.Dougherty T. J., et al. , “Photodynamic therapy,” J. NCI. 90(12), 889–905 (1998). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Niedre M. J., et al. , “In-vitro tests of the validity of singlet oxygen luminescence measurements as a dose metric in photodynamic therapy,” Cancer Res. 63(22), 7986–7994 (2003). [PubMed] [Google Scholar]
  • 3.Niedre M. J., et al. , “Singlet oxygen luminescence as an in vivo photodynamic therapy dose metric: validation in normal mouse skin with topic amino-levulinic acid,” Brit. J. Cancer 92(2), 298–304 (2005). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Jarvi M. T., et al. , “Singlet oxygen luminescence dosimetry (SOLD) for photodynamic therapy: current status, challenges and future prospects,” Photochem. Photobiol. 82, 1198–1210 (2006). 10.1562/2006-05-03-IR-891 [DOI] [PubMed] [Google Scholar]
  • 5.Niedre M. J., Patterson M. S., Wilson B. C., “Direct near-infrared luminescence detection of singlet oxygen generated by photodynamic therapy in cells in vitro and tissues in vivo,” Photochem. Photobiol. 75, 382–391 (2002). 10.1562/0031-8655(2002)0750382DNILDO2.0.CO2 [DOI] [PubMed] [Google Scholar]
  • 6.Robinson D. J., et al. , “Fluorescence photobleaching of ALA-induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: the effect of light dose and irradiance and the resulting biological effect,” Photochem. Photobiol. 67, 140–149 (1998). 10.1111/php.1998.67.issue-1 [DOI] [PubMed] [Google Scholar]
  • 7.Lee T. K., Foster T. H., “Integrated spectroscopy and PDT delivery for various treatment geometries,” in Frontiers in Optics 2008/Laser Science XXIV/Plasmonics and Metamaterials/Optical Fabrication and Testing, Optical Society of America, Rochester, New York: (2008). [Google Scholar]
  • 8.Foster T. H., et al. , “Intratumor administration of the photosensitizer pc 4 affords photodynamic therapy efficacy and selectivity at short drug-light intervals,” Transl. Oncol. 3(2), 135–41 (2010). 10.1593/tlo.09295 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Mitra S., Foster T. H., “In vivo confocal fluorescence imaging of the intratumor distribution of the photosensitizer mono-L-aspartylchlorin-e6,” Neoplasia. 10(5), 429–438 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Seshadri M., et al. , “Light delivery over extended time periods enhances the effectiveness of photodynamic therapy,” Clin. Cancer Res. 14(9), 2796–805 (2008). 10.1158/1078-0432.CCR-07-4705 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Cheung R., et al. , “Correlation of in vivo photosensitizer fluorescence and photodynamic-therapy-induced depth of necrosis in a murine tumor model,” J. Biomed. Opt. 8(2), 248–252 (2003). 10.1117/1.1560011 [DOI] [PubMed] [Google Scholar]
  • 12.Busch T. M., et al. , “Increasing damage to tumor blood vessels during motexafin lutetium-PDT through use of low fluence rate,” Radiat. Res. 174(3), 331–40 (2010). 10.1667/RR2075.1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Wang K. K.-H., et al. , “Explicit dosimetry for photodynamic therapy: macroscopic singlet oxygen modeling,” J. Biophoton. 3(5–6), 304–318 (2010). 10.1002/jbio.v3:5/6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Dysart J. S., Patterson M. S., “Characterization of Photofrin photobleaching for singlet oxygen dose estimation during photodynamic therapy of MLL cells in vitro,” Phys. Med. Biol. 50, 2597–2616 (2005). 10.1088/0031-9155/50/11/011 [DOI] [PubMed] [Google Scholar]
  • 15.Finlay J. C., et al. , “Photobleaching kinetics of Photofrin in vivo and in multicell tumour spheroids indicate two simultaneous bleaching mechanisms,” Phys. Med. Biol. 49, 4837–60 (2004). 10.1088/0031-9155/49/21/001 [DOI] [PubMed] [Google Scholar]
  • 16.Zhu T. C., et al. , “Macroscopic modeling of the singlet oxygen production during PDT,” Proc. SPIE 6427, 1–12 (2007). 10.1117/12.701387 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Liu B., Farrell T. J., Patterson M. S., “A dynamic model for ALA-PDT of skin: simulation of temporal and spatial distributions of ground-state oxygen, photosensitizer and singlet oxygen,” Phys. Med. Biol. 55, 5913–5932 (2010). 10.1088/0031-9155/55/19/019 [DOI] [PubMed] [Google Scholar]
  • 18.Zhu T. C., et al. , “Comparison of singlet oxygen threshold dose for PDT,” Proc. SPIE 8931, 89310I (2014). 10.1117/12.2039719 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Whiteley J. P., Gavaghan D. J., Hahn C. E. W., “Mathematical modeling of oxygen transport to tissue,” J. Math. Biol. 44, 503–522 (2002). 10.1007/s002850200135 [DOI] [PubMed] [Google Scholar]
  • 20.Wiedeman M. P., “Dimensions of blood vessels from distributing artery to collecting vein,” Circ. Res. 12, 375–378 (1963). 10.1161/01.RES.12.4.375 [DOI] [PubMed] [Google Scholar]
  • 21.Baish J. W., et al. , “Scaling rules for diffusive drug delivery in tumor and normal tissues,” Proc. Natl. Acad. Sci. 108, 1799–1803 (2011). 10.1073/pnas.1018154108 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Lauk S., et al. , “Comparative morphometric study of tumor vasculature in human squamous cell carcinomas and their xenotransplants in athymic nude mice,” Cancer Res. 49(16), 4557–4561 (1989). [PubMed] [Google Scholar]
  • 23.Murray J. D., “On the molecular mechanism of facilitated oxygen diffusion by haemoglobin and myoglobin,” Proc. Roy. Soc. Lond. B. 178, 95–110 (1971). 10.1098/rspb.1971.0054 [DOI] [PubMed] [Google Scholar]
  • 24.Wang K. K., Mitra S., Foster T. H., “A comprehensive mathematical model of microscopic dose deposition in photodynamic therapy,” Med. Phys. 34, 282–293 (2007). 10.1118/1.2401041 [DOI] [PubMed] [Google Scholar]
  • 25.Carreau A., et al. , “Why is the partial oxygen pressure of human tissues a crucial parameter? Small molecules and hypoxia,” J. Cell. Mol. Med. 15, 1239–1253 (2011). 10.1111/jcmm.2011.15.issue-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Chaplin H., Mollison P. L., Vetter H., “The body/venous hematocrit ratio: Its constancy over a wide hematocrit range,” J. Clin. Invest. 32(12), 1309–1316 (1953). 10.1172/JCI102859 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Williams A. J., “Assessing and interpreting arterial blood gases and acid-base balance,” Brit. Med. J. 317, 1213–1216 (1998). 10.1136/bmj.317.7167.1213 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Pittman R. N., Regulation of Tissue Oxygenation, Morgan & Claypool Life Sciences, San Rafael, California: (2011). [PubMed] [Google Scholar]

Articles from Journal of Biomedical Optics are provided here courtesy of Society of Photo-Optical Instrumentation Engineers

RESOURCES